Institutional investors purchased a net $337.7 thousand shares of OCAT during the quarter ended December 2014, and now own 0.99% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 61.0 Thousand shares of Ocata Therapeutics Inc
MORGAN STANLEY & CO. LLC Bought 54.2 Thousand shares of Ocata Therapeutics Inc